| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 |
Form 4: Sawicki Mark W, Chief Scientific Officer
Sold 10,000 shares ($199K) |
| 12 Nov 2026 |
Form 4: Hancock Daniel M, Director
Received 74,379 shares by exercise or conversion ($737K) · Sold 74,379 shares ($1.5M) |
| 10 Nov 2026 | 144 |
| 09 Nov 2026 | 144 |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
Third quarter revenue grew 14% year-over-year to $50.2 million |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 11 Aug 2026 |
Form 4: Shelton Jerrell, Director
Sold 28,800 shares ($429K) |
| 11 Aug 2026 | 144 |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
Second quarter revenue grew 8% year-over-year to $49.0 million |
| 29 Jul 2026 | SCHEDULE 13G/A |
| 22 Jun 2026 | FORM S-8 |
| 22 Jun 2026 | 15-12G |
| 12 Jun 2026 |
Form 4: Zecchini Edward J, Chief Digital and Tech Officer
Received 1,400 shares by exercise or conversion ($6.72K) · Sold 1,400 shares ($21.3K) · Received 33,600 shares by exercise or conversion ($161K) · 1 more |
| 11 Jun 2026 | 144 |
| 10 Jun 2026 | 144 |
| 09 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders
(as amended by the First Amendment (effective February 25, 2021), the Second Amendment (effective April 30, 2021), the Third Amendment (effective May 17, 2024), and the Fourth Amendment (effective June 5, 2026)) |
Loading...